Patents Assigned to Clarian Health Partners
  • Publication number: 20120322040
    Abstract: A doll for educating caregivers about Shaken Baby Syndrome comprises a head portion, a body, and may comprise transparent skin. The head portion may have a simulated brain disposed therein. The head portion is floppably connected to the body. The doll may further comprise a first chamber and a second chamber containing simulated blood, the simulated blood being visible in the first chamber after acceleration experienced during a shaking episode, but otherwise being concealed from view in the second chamber. A plurality of acceleration sensors may be disposed within the doll to detect acceleration experienced during a shaking episode, and the plurality of acceleration sensors may trigger warnings to the caregiver when portions of the doll experience acceleration sufficient to endanger an infant.
    Type: Application
    Filed: August 28, 2012
    Publication date: December 20, 2012
    Applicant: CLARIAN HEALTH PARTNERS, INC.
    Inventor: Nena R. Ray
  • Publication number: 20110165126
    Abstract: An improved tissue graft construct comprising submucosa of a warm-blooded vertebrate and a preselected group of eukaryotic cells are described. The improved tissue graft constructs can be used in accordance with the present invention to enhance the repair of damaged or diseased tissues in vivo.
    Type: Application
    Filed: August 9, 2010
    Publication date: July 7, 2011
    Applicants: Purdue Research Foundation, Clarian Health Partners, Inc.
    Inventors: Stephen F. Badylak, Kristina Lindberg, George B. Boder, Sherry Voytik-Harbin
  • Patent number: 7820634
    Abstract: A composition useful for the production of transformed eukaryotic cells is described. The composition comprises submucosal tissue and a nucleic acid sequence. The nucleic acid sequence is typically recombinant DNA including gene(s) encoding for one or more biofunctional proteins. The submucosal tissue component of the present composition comprises the tunica submucosa of vertebrate intestine delaminated from the tunica muscularis and at least the luminal portion of the tunica mucosa. Injection or implantation of the composition into a host induces the formation of transformed cells capable of expressing gene(s) encoded by the nucleic acid sequence.
    Type: Grant
    Filed: May 2, 2007
    Date of Patent: October 26, 2010
    Assignees: Purdue Research Foundation, The Regents of the University of Michigan, Clarian Health Partners, Inc.
    Inventors: Stephen F. Badylak, Jeffrey Bonadio, Sherry Voytik
  • Patent number: 7815686
    Abstract: An intestinal submucosa tissue graft construct for use in repairing diseased or damaged tissues is provided. The graft construct comprises vertebrate intestinal submucosa tissue, added endothelial cells, and at least one additional preselected, exogenous population of cells which enhances initiation of the formation of vessel-like structures in the graft. The preselected population of cells can be a population of non-keratinized or keratinized epithelial cells or a population of mesodermally derived cells selected from the group consisting of fibroblasts, smooth muscle cells, skeletal muscle cells, cardiac muscle cells, multi-potential progenitor cells, pericytes, osteogenic cells, and any other suitable cell type, preferably selected based on the tissue to be repaired. Methods for enhancing the vascularization in vivo of these intestinal submucosa tissue graft constructs and for preparing these graft constructs are also provided.
    Type: Grant
    Filed: May 2, 2003
    Date of Patent: October 19, 2010
    Assignees: Purdue Research Foundation, Clarian Health Partners, Inc.
    Inventor: Stephen F. Badylak
  • Patent number: 7771717
    Abstract: An improved tissue graft construct comprising submucosa of a warm-blooded vertebrate and a preselected group of eukaryotic cells are described. The improved tissue graft constructs can be used in accordance with the present invention to enhance the repair of damaged or diseased tissues in vivo.
    Type: Grant
    Filed: February 13, 2007
    Date of Patent: August 10, 2010
    Assignees: Purdue Research Foundation, Clarian Health Partners, Inc.
    Inventors: Stephen F. Badylak, Khristina Lindberg, George B. Boder, Sherry Voytik-Harbin
  • Publication number: 20090252716
    Abstract: An in vitro method is provided for identifying nuclear receptors abnormally expressed by brain tumor stem cells and a corresponding ligand which, if administered to brain tumor stem cells (BTSC's), is capable of inhibiting cell proliferation. Once the nuclear receptor/ligand combination has been identified, it can be utilized in vitro and in vivo to inhibit the proliferation and survival of the cancerous stem cells and ultimately affect proliferation and survival of tumors. The method can be utilized alone or in combination with other treatment methods. The method can also be utilized with regard to other forms of cancer which have cancerous stem cells associated therewith and which abnormally express one or more nuclear receptors.
    Type: Application
    Filed: April 3, 2009
    Publication date: October 8, 2009
    Applicant: Clarian Health Partners, Inc. d/b/a Methodist Research Institute
    Inventor: John J. Bright
  • Patent number: 7509156
    Abstract: A blood glucose maintenance system for use by hyperglycemic individuals measures their blood glucose level and calculates an appropriate glucose or insulin dosage based on the measurement. Recheck intervals responsive to dosage history are determined. Warning or alert messages or signals are produced if certain measurements or calculations fall outside established normal ranges. It is particularly useful for patients in a hospital or in-patient environment.
    Type: Grant
    Filed: May 18, 2005
    Date of Patent: March 24, 2009
    Assignee: Clarian Health Partners, Inc.
    Inventor: Samuel J. Flanders
  • Patent number: 7123137
    Abstract: A patient safety alerting system and methods for providing enhanced patient safety using a patient alerting system are provided. An illustrative patient safety alerting system comprises an output device comprising a set of indicators, each indicator displaying one of a plurality of indicator states, each of the indicator states indicating a level of compliance with patient safety procedures; a set of status lists, each status list corresponding to its respective indicator, wherein the displayed indicator state of the respective indicator corresponds to information in the respective status list, each status list provided for containing information regarding the status of a patient for a component or activity; a processing unit operatively connected to the output device for processing changes to the status lists and corresponding indicators; and an input device operatively connected to the processing unit and configured to interface with a user to allow the user to access information in any of the status lists.
    Type: Grant
    Filed: June 28, 2004
    Date of Patent: October 17, 2006
    Assignee: Clarian Health Partners, Inc.
    Inventors: David Alan Heck, Kathryn Gardner Rapala, Philip H. Canada
  • Patent number: 6918396
    Abstract: A method for surgical repair of damaged or diseased head and neck tissues is described. In one aspect of the invention tissue graft constructs comprising vertebrate submucosa or vertebrate basement membrane materials are used to repair and promote growth of endogenous vocal cord tissue.
    Type: Grant
    Filed: December 1, 1999
    Date of Patent: July 19, 2005
    Assignees: Purdue Research Foundation, Clarian Health Partners, Inc.
    Inventors: Stephen F. Badylak, Alan R. Spievack
  • Patent number: 6087157
    Abstract: A device for analyzing the in-vitro growth properties of cells is disclosed. The device comprises an upper and lower chamber separated by a growth substrate interface comprising submucosa, preferably tunical submucosa, from a warm-blooded vertebrae. Methods for culturing eukaryotic cells and studying their growth characteristics, including the invasive growth characteristics of tumor cells, on the submucosal matrix are described.
    Type: Grant
    Filed: March 25, 1997
    Date of Patent: July 11, 2000
    Assignees: Clarian Health Partners, Purdue Research Foundation
    Inventors: Stephen F. Badylak, George Boder, Sherry L. Voytik-Harbin, Robert J. Demeter, John K. Critser, Chi Liu
  • Patent number: 5968096
    Abstract: A perforated unitary multi-laminar tissue graft construct and method for preparing such construct is described. The method comprises overlapping strips of submucosa tissue with other strips of submucosal tissue, compressing at least the overlapped portions of said strips between two surfaces under conditions that allow or promote dehydration of the compressed submucosa sheets, and perforating the resulting unitary tissue graft construct. The perforated tissue graft compositions have enhanced mechanical and remodeling properties relative to non-perforated submucosal tissue grafts.
    Type: Grant
    Filed: August 6, 1997
    Date of Patent: October 19, 1999
    Assignees: Purdue Research Foundation, Clarian Health Partners
    Inventors: Bryan Whitson, Boyle Cheng, Stephen F. Badylak